Joseph Douglas Mancias, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Receptor Coactivators | 10 | 2024 | 62 | 3.780 |
Why?
|
Autophagy | 17 | 2024 | 1349 | 2.180 |
Why?
|
Ferritins | 8 | 2024 | 600 | 2.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 16 | 2024 | 1762 | 1.480 |
Why?
|
Erythropoiesis | 3 | 2019 | 691 | 1.360 |
Why?
|
Iron | 12 | 2024 | 1811 | 1.340 |
Why?
|
Pancreatic Neoplasms | 22 | 2024 | 5454 | 1.280 |
Why?
|
Iron-Sulfur Proteins | 2 | 2022 | 84 | 0.990 |
Why?
|
COP-Coated Vesicles | 5 | 2008 | 39 | 0.790 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 7 | 2024 | 1765 | 0.710 |
Why?
|
Proteomics | 9 | 2022 | 3907 | 0.640 |
Why?
|
Phagosomes | 2 | 2015 | 193 | 0.530 |
Why?
|
Radiosurgery | 5 | 2023 | 1328 | 0.500 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 853 | 0.480 |
Why?
|
Histocompatibility Antigens Class I | 4 | 2024 | 1362 | 0.470 |
Why?
|
Oncogenes | 1 | 2020 | 1232 | 0.450 |
Why?
|
Homeostasis | 6 | 2024 | 3338 | 0.430 |
Why?
|
Anemia | 2 | 2022 | 1514 | 0.420 |
Why?
|
Lysosomes | 6 | 2024 | 932 | 0.410 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2015 | 572 | 0.380 |
Why?
|
Adenocarcinoma | 8 | 2022 | 6363 | 0.360 |
Why?
|
Biological Availability | 3 | 2022 | 387 | 0.340 |
Why?
|
Protein Sorting Signals | 2 | 2008 | 273 | 0.340 |
Why?
|
Tumor Escape | 2 | 2024 | 371 | 0.330 |
Why?
|
Stress, Physiological | 1 | 2016 | 1405 | 0.300 |
Why?
|
Endoplasmic Reticulum | 4 | 2008 | 1132 | 0.300 |
Why?
|
R-SNARE Proteins | 1 | 2007 | 73 | 0.280 |
Why?
|
Cysteine | 2 | 2022 | 898 | 0.270 |
Why?
|
Peptide Hydrolases | 2 | 2020 | 608 | 0.270 |
Why?
|
Animals | 33 | 2024 | 168800 | 0.250 |
Why?
|
Neoplasms | 7 | 2023 | 22344 | 0.240 |
Why?
|
Sulfur | 2 | 2022 | 158 | 0.240 |
Why?
|
Proteome | 3 | 2021 | 1896 | 0.240 |
Why?
|
Vesicular Transport Proteins | 4 | 2008 | 376 | 0.240 |
Why?
|
Bone Morphogenetic Protein 6 | 1 | 2024 | 58 | 0.220 |
Why?
|
Mice | 22 | 2024 | 81839 | 0.220 |
Why?
|
Cell Line, Tumor | 12 | 2024 | 17071 | 0.210 |
Why?
|
Protein Folding | 1 | 2007 | 868 | 0.210 |
Why?
|
Alstrom Syndrome | 1 | 2022 | 11 | 0.210 |
Why?
|
Glutamine | 2 | 2017 | 575 | 0.200 |
Why?
|
Bardet-Biedl Syndrome | 1 | 2022 | 51 | 0.200 |
Why?
|
Glyceraldehyde | 1 | 2021 | 5 | 0.200 |
Why?
|
Propane | 1 | 2021 | 12 | 0.200 |
Why?
|
Comprehension | 2 | 2018 | 636 | 0.190 |
Why?
|
Wolfram Syndrome | 1 | 2021 | 14 | 0.190 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2020 | 2879 | 0.190 |
Why?
|
Cation Transport Proteins | 1 | 2024 | 325 | 0.190 |
Why?
|
Cell Proliferation | 7 | 2021 | 10433 | 0.180 |
Why?
|
Mitochondria | 4 | 2023 | 3672 | 0.180 |
Why?
|
Amino Acid Transport System y+ | 1 | 2021 | 41 | 0.180 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2021 | 72 | 0.180 |
Why?
|
Particle Accelerators | 1 | 2021 | 172 | 0.180 |
Why?
|
Hemochromatosis | 1 | 2022 | 175 | 0.180 |
Why?
|
Epitopes | 1 | 2007 | 2523 | 0.180 |
Why?
|
Protein Transport | 4 | 2014 | 1939 | 0.170 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2021 | 201 | 0.170 |
Why?
|
Ameloblasts | 1 | 2020 | 17 | 0.170 |
Why?
|
Sex Reassignment Surgery | 1 | 2023 | 164 | 0.170 |
Why?
|
Cell Respiration | 1 | 2020 | 197 | 0.170 |
Why?
|
Cryoelectron Microscopy | 1 | 2024 | 645 | 0.170 |
Why?
|
Iron Overload | 1 | 2022 | 245 | 0.170 |
Why?
|
Prenylation | 1 | 2019 | 36 | 0.160 |
Why?
|
Phagocytes | 1 | 2021 | 292 | 0.160 |
Why?
|
Colonic Neoplasms | 2 | 2023 | 2532 | 0.160 |
Why?
|
Humans | 55 | 2024 | 766117 | 0.160 |
Why?
|
Crystallography, X-Ray | 5 | 2018 | 1947 | 0.160 |
Why?
|
Transcription Factors | 5 | 2022 | 12130 | 0.160 |
Why?
|
Incisor | 1 | 2020 | 170 | 0.160 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 303 | 0.160 |
Why?
|
Oxidoreductases | 2 | 2024 | 409 | 0.150 |
Why?
|
Mutation | 5 | 2024 | 30209 | 0.150 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3604 | 0.150 |
Why?
|
Models, Molecular | 6 | 2024 | 5382 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 247 | 0.140 |
Why?
|
Protein Binding | 5 | 2024 | 9301 | 0.140 |
Why?
|
Alanine | 1 | 2020 | 613 | 0.140 |
Why?
|
Biological Assay | 2 | 2021 | 626 | 0.140 |
Why?
|
K562 Cells | 1 | 2019 | 644 | 0.140 |
Why?
|
Serine | 1 | 2020 | 828 | 0.140 |
Why?
|
Hemolysis | 1 | 2019 | 408 | 0.130 |
Why?
|
Microtubule-Associated Proteins | 2 | 2024 | 1068 | 0.130 |
Why?
|
Metabolic Networks and Pathways | 2 | 2020 | 798 | 0.130 |
Why?
|
Acetamides | 1 | 2018 | 260 | 0.130 |
Why?
|
Centrioles | 1 | 2016 | 80 | 0.130 |
Why?
|
Membrane Proteins | 3 | 2021 | 7850 | 0.130 |
Why?
|
Protein Kinases | 1 | 2023 | 1611 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 1138 | 0.130 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2221 | 0.120 |
Why?
|
Chloroquine | 2 | 2020 | 276 | 0.120 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2016 | 237 | 0.120 |
Why?
|
Internet | 2 | 2018 | 3107 | 0.120 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 678 | 0.120 |
Why?
|
Pancreatectomy | 1 | 2019 | 825 | 0.120 |
Why?
|
Amino Acids | 1 | 2021 | 1710 | 0.120 |
Why?
|
RNA | 2 | 2023 | 2716 | 0.110 |
Why?
|
Carrier Proteins | 1 | 2007 | 4910 | 0.110 |
Why?
|
Consumer Health Information | 1 | 2016 | 215 | 0.110 |
Why?
|
Thiophenes | 1 | 2018 | 570 | 0.110 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2023 | 1897 | 0.110 |
Why?
|
Models, Biological | 4 | 2021 | 9445 | 0.110 |
Why?
|
Mice, Knockout | 4 | 2024 | 14456 | 0.110 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22341 | 0.110 |
Why?
|
Protein Biosynthesis | 1 | 2020 | 2091 | 0.110 |
Why?
|
Cell Line | 4 | 2020 | 15546 | 0.110 |
Why?
|
Binding Sites | 4 | 2024 | 6001 | 0.100 |
Why?
|
Thalidomide | 1 | 2018 | 886 | 0.100 |
Why?
|
Down-Regulation | 1 | 2020 | 2927 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2023 | 6961 | 0.100 |
Why?
|
Microcephaly | 1 | 2016 | 427 | 0.100 |
Why?
|
Doxorubicin | 1 | 2019 | 2226 | 0.100 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2897 | 0.100 |
Why?
|
Zebrafish | 3 | 2020 | 3035 | 0.090 |
Why?
|
Up-Regulation | 1 | 2020 | 4133 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2019 | 2864 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1885 | 0.090 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2023 | 1642 | 0.090 |
Why?
|
Substrate Specificity | 1 | 2014 | 1751 | 0.080 |
Why?
|
Protein Structure, Secondary | 3 | 2008 | 1211 | 0.080 |
Why?
|
Lymphoma | 1 | 2019 | 1896 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5336 | 0.080 |
Why?
|
Proteins | 2 | 2022 | 5995 | 0.080 |
Why?
|
Genes, ras | 1 | 2011 | 656 | 0.080 |
Why?
|
Qb-SNARE Proteins | 1 | 2008 | 34 | 0.080 |
Why?
|
Microfilament Proteins | 1 | 2014 | 1130 | 0.080 |
Why?
|
Qa-SNARE Proteins | 1 | 2008 | 51 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2018 | 3436 | 0.080 |
Why?
|
Signal Transduction | 6 | 2021 | 23605 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1054 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2024 | 4649 | 0.070 |
Why?
|
Immunotherapy | 2 | 2021 | 4746 | 0.070 |
Why?
|
Carcinoma | 1 | 2019 | 2313 | 0.070 |
Why?
|
Molecular Sequence Data | 4 | 2008 | 17597 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2018 | 2898 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3238 | 0.070 |
Why?
|
Hydroxychloroquine | 1 | 2011 | 429 | 0.070 |
Why?
|
Mass Spectrometry | 3 | 2021 | 2195 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5695 | 0.070 |
Why?
|
SNARE Proteins | 1 | 2007 | 80 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11859 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2023 | 8612 | 0.070 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2007 | 198 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2024 | 11906 | 0.070 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2007 | 165 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2021 | 13635 | 0.060 |
Why?
|
Amino Acid Sequence | 4 | 2019 | 13400 | 0.060 |
Why?
|
Molecular Structure | 2 | 2020 | 1881 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2021 | 3637 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2008 | 1159 | 0.060 |
Why?
|
Cricetinae | 1 | 2008 | 2413 | 0.060 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3942 | 0.060 |
Why?
|
NF-kappa B | 2 | 2024 | 2495 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4399 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2008 | 1716 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10260 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5791 | 0.050 |
Why?
|
Pancreas | 2 | 2023 | 1699 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2024 | 4263 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2023 | 3678 | 0.050 |
Why?
|
Protein Conformation | 2 | 2007 | 3946 | 0.050 |
Why?
|
Biological Transport | 1 | 2007 | 2080 | 0.050 |
Why?
|
Male | 14 | 2023 | 363935 | 0.050 |
Why?
|
Claudins | 1 | 2023 | 118 | 0.050 |
Why?
|
Glucose | 1 | 2014 | 4335 | 0.050 |
Why?
|
Ligands | 2 | 2019 | 3274 | 0.050 |
Why?
|
Membrane Transport Proteins | 1 | 2007 | 1029 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4521 | 0.050 |
Why?
|
Neurons | 1 | 2020 | 9521 | 0.050 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 524 | 0.050 |
Why?
|
Tacrolimus Binding Protein 1A | 1 | 2020 | 40 | 0.040 |
Why?
|
Multiprotein Complexes | 1 | 2007 | 1107 | 0.040 |
Why?
|
Aging | 1 | 2020 | 8723 | 0.040 |
Why?
|
Enterocytes | 1 | 2022 | 220 | 0.040 |
Why?
|
Nerve Tissue | 1 | 2020 | 78 | 0.040 |
Why?
|
Anal Canal | 1 | 2023 | 376 | 0.040 |
Why?
|
Pyrimidines | 2 | 2024 | 3050 | 0.040 |
Why?
|
Female | 13 | 2023 | 396233 | 0.040 |
Why?
|
Fiducial Markers | 1 | 2021 | 134 | 0.040 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2020 | 199 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 197 | 0.040 |
Why?
|
Glutathione | 1 | 2021 | 589 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2016 | 11642 | 0.040 |
Why?
|
Computer Simulation | 2 | 2016 | 6254 | 0.040 |
Why?
|
Codon | 1 | 2020 | 599 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 3733 | 0.040 |
Why?
|
RNA, Transfer | 1 | 2020 | 284 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 40108 | 0.040 |
Why?
|
Peptide Library | 1 | 1999 | 351 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2020 | 656 | 0.040 |
Why?
|
Metagenomics | 1 | 2021 | 473 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2019 | 399 | 0.040 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2007 | 1836 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 715 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18076 | 0.040 |
Why?
|
Vagina | 1 | 2023 | 849 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 800 | 0.040 |
Why?
|
Glutaminase | 1 | 2017 | 31 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2020 | 454 | 0.040 |
Why?
|
Glycine | 1 | 2020 | 671 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2018 | 539 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1801 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1743 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2023 | 2863 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1837 | 0.030 |
Why?
|
Organizations, Nonprofit | 1 | 2016 | 105 | 0.030 |
Why?
|
Cell Membrane | 1 | 2005 | 3635 | 0.030 |
Why?
|
Government | 1 | 2016 | 161 | 0.030 |
Why?
|
Selection Bias | 1 | 2017 | 359 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2016 | 407 | 0.030 |
Why?
|
Epithelium | 1 | 2020 | 1604 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2016 | 297 | 0.030 |
Why?
|
Leucovorin | 1 | 2016 | 643 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2024 | 2570 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3051 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2020 | 1250 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 565 | 0.030 |
Why?
|
Amyloid | 1 | 1999 | 848 | 0.030 |
Why?
|
Neural Stem Cells | 1 | 2021 | 897 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2022 | 2390 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2020 | 2062 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2016 | 874 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1872 | 0.030 |
Why?
|
Rats | 2 | 2020 | 23717 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2120 | 0.030 |
Why?
|
Protein Structure, Tertiary | 2 | 2014 | 3751 | 0.030 |
Why?
|
Prostate | 1 | 2022 | 1758 | 0.030 |
Why?
|
Pinocytosis | 1 | 2014 | 64 | 0.030 |
Why?
|
Ownership | 1 | 2016 | 338 | 0.030 |
Why?
|
Aged | 6 | 2023 | 171219 | 0.030 |
Why?
|
Mass Media | 1 | 2016 | 302 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 992 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2144 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 8062 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2021 | 2474 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3159 | 0.030 |
Why?
|
Axons | 1 | 2020 | 1677 | 0.030 |
Why?
|
Complementary Therapies | 1 | 2016 | 486 | 0.020 |
Why?
|
Metabolomics | 1 | 2021 | 1667 | 0.020 |
Why?
|
Gene Deletion | 1 | 2020 | 2667 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2327 | 0.020 |
Why?
|
Fluorouracil | 1 | 2016 | 1648 | 0.020 |
Why?
|
Pedigree | 1 | 2019 | 4535 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3586 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6102 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2017 | 781 | 0.020 |
Why?
|
Stents | 1 | 2023 | 3191 | 0.020 |
Why?
|
Drug Discovery | 1 | 2019 | 1065 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1194 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3048 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2021 | 2894 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3140 | 0.020 |
Why?
|
Middle Aged | 6 | 2020 | 223083 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 2031 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1884 | 0.020 |
Why?
|
Brain | 1 | 2016 | 27177 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1973 | 0.020 |
Why?
|
Isoenzymes | 1 | 2014 | 1688 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5020 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4352 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7559 | 0.020 |
Why?
|
Information Dissemination | 1 | 2016 | 1142 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5196 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3684 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8525 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9540 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3530 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 81565 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2016 | 18967 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10087 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6506 | 0.020 |
Why?
|
Research Design | 1 | 2022 | 6206 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5450 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2332 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5776 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10737 | 0.020 |
Why?
|
Clathrin | 1 | 2007 | 259 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2782 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12775 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2007 | 405 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16716 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2007 | 1430 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21513 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1742 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18321 | 0.010 |
Why?
|
Prognosis | 1 | 2023 | 29912 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13468 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 14066 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8038 | 0.010 |
Why?
|
United States | 2 | 2019 | 72920 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7424 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54812 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2007 | 2677 | 0.010 |
Why?
|
Child | 1 | 2022 | 80573 | 0.010 |
Why?
|
Adult | 2 | 2019 | 223139 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 59515 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65219 | 0.010 |
Why?
|